APOQUEL

Film-Coated Tablets for Dogs
Antipruritic film-coated tablets

Laboratory
ZOETIS SPAIN, SLU

Pharmaceutical form:
Coated tablet (Comp.rec.)

Composition: per tablet:
Apoquel 3,6 mg: 3,6 mg as oclacitinib maleate.
Apoquel 5,4 mg: 5,4 mg oclacitinib maleate.
Apoquel 16 mg: 16 mg oclacitinib maleate.

Indications and target species:
Dogs: Treatment of pruritus related to allergic dermatitis; treatment of clinical manifestations of atopic dermatitis dermatitis.

Contraindications:
• Do not use in dogs less than 12 months of age or weighing less than 3 kg.
• Do not use in dogs with evidence of immunosuppression, such as hyperadrenocorticism, or with evident progressive malignancy, since the active substance has not been evaluated in these cases.

Route of administration:
Oral administration. Posology
• The recommended starting dose is 0,4 to 0,6 mg oclacitinib/kg body weight, administered orally, twice daily for 14 days.
• As maintenance therapy, the same dose (0,4 to 0,6 mg oclacitinib/kg body weight) should be administered once daily only. Long-term maintenance therapy should be based on an individual risk benefit assessment.
• These tablets can be taken with or without food.

Wait time:
Not applicable.

Conservation mode:
Store at a temperature below 25 °C. Any remaining tablet half must be placed back in the opened blister pack and stored (maximum 3 days) in the original cardboard packaging.

Remarks:
With veterinary prescription.

Presentation:
Formats of 20, 50 or 100 tablets.

Reg No.:EU/2/13/154/001-009

DATA SHEET 

APOQUEL